NFE2L2 and esophageal cancer: Although direct evidence linking the NRF2-mediated transcriptional activation of ABC transporters to chemoresistance in esophageal cancer (EC) is currently limited, the overexpression of ABC transporters in ESCC, combined with frequent NRF2 pathway alterations, suggests a potential mechanistic link [34].